Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?

D'Amico F, Solitano V, Peyrin-Biroulet L, Danese S

DOI: 10.1080/14712598.2020.1817374
Published: 2021 Jan
Container: Expert opinion on biological therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2020.1817374,
  title = {Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?},
  author = {D'Amico F and Solitano V and Peyrin-Biroulet L and Danese S},
  year = {2021},
  journal = {Expert opinion on biological therapy},
  doi = {10.1080/14712598.2020.1817374},
  url = {https://doi.org/10.1080/14712598.2020.1817374}
}

RIS

TY  - JOUR
TI  - Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?
AU  - D'Amico F
AU  - Solitano V
AU  - Peyrin-Biroulet L
AU  - Danese S
PY  - 2021
JO  - Expert opinion on biological therapy
DO  - 10.1080/14712598.2020.1817374
UR  - https://doi.org/10.1080/14712598.2020.1817374
ER  -

APA

F, D., V, S., L, P., & S, D. (2021). Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?. Expert opinion on biological therapy. https://doi.org/10.1080/14712598.2020.1817374

Source records

pubmed · retrieved 2026-09-26T03:24:41.316Z